This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast May 8, 2025 Skin cancer is the most common cancer in the United…
A recent survey surprisingly found only 41% of physicians were “very confident” about their ability…
Originally broadcast April 22, 2025 Health and Human Services Secretary Robert F. Kennedy Jr. announced…
Originally broadcast April 17, 2025 The U.S. healthcare system could save up to 500,000 lives…
Originally broadcast April 10, 2025 Eccentric billionaire Howard Hughes founded his eponymous Medical Institute over…
Originally broadcast April 3, 2025 Roughly 85% of respondents to a survey cited by Michael…